암학회-2018-봄-브로셔-0403.indd

Transcription

1 대한암학회서울특별시종로구새문안로 92 광화문오피시아 1824호 (03186) Tel 02) Fax 02) 관악우체국 요금별납 Korean Cancer Association 44 th Annual Meeting & 4 th International Cancer Conference 제 44 차대한암학회학술대회및 제 4 차국제암컨퍼런스 2018 년 6 월 21( 목 ) - 22 일 ( 금 ) 서울롯데호텔 ( 소공동 ) 대한암학회 Korean Cancer Association

2 44 th Annual Meeting of Korean Cancer Association & 4th International Cancer Conference 초청의글 제 44 차대한암학회학술대회및제 4 차국제암컨퍼런스 대한암학회회원및암연구자여러분, 일자장소주최공식언어홈페이지 2018년 6월 21( 목 ) - 22일 ( 금 ) 서울롯데호텔 ( 소공동 ) 대한암학회영어, 한국어 Contents 01 초청의글 02 Plenary Speakers 03 초록접수 04 일정표 08 프로그램 21 사전등록 제44차대한암학회학술대회및제4차국제암컨퍼런스가 2018년 6월 21-22일, 양일간서울롯데호텔에서개최됩니다. 본대회는암연구에종사하는기초및임상연구자약 1,500여명이참석하는국내최대의종양학학술대회로써 2014년부터국제대회로규모를확대하며학술적위상을높여가고있습니다. 특히, 지난해열린 43차학술대회는제24차아시아태평양암학회 (APCC 2017) 와공동개최되어, 전세계 47개국에서 2,300여명이참가하여아시아전반의암관련이슈와최신연구결과를공유하는큰성과를이루었습니다. 이러한성과에힘입어앞으로도대한암학회가아시아암관련대회에서중요한대회로자리매김할수있도록회원및암연구자여러분의많은성원을부탁드립니다. 이번대회해외 Plenary 연자로는암유전체연구로잘알려진영국 Wellcome Trust Sanger Institute 소속의 Peter Campbell 박사와 Ras biology 및 biochemistry 연구로유명한미국 UCSF Helen Diller Family Comprehensive Cancer Center의 Frank McCormick 교수를초청하였습니다. 국내 Plenary 연자로는국내유방외과학의학문적발전에크게기여한서울의대외과노동영교수와, 인슐린유사성장인자수용체매개발암기전과표적항암제의내성기전을규명하고복합항암요법및항암신약중개연구에서활발한연구를수행하는서울대약대이호영교수를초청하였습니다. 또한, 임상및기초분야에서암연구자들의최근관심을반영한심포지엄을비롯하여국내 외암관련학회들과의공동심포지엄을준비하였고이외각기관에서진행하는많은암연구들과주요이슈들이발표될것입니다. 부디많은회원및암연구자여러분께서참석하시어암연구의혁신적인연구결과를공유하고다양한의견을나눌수있는토론의장을만들어주시면감사하겠습니다. 대한암학회회장최은경 Major Sponsors 이사장김열홍학술위원장김태유

3 2 제44차 대한암학회 학술대회 및 제4차 국제암컨퍼런스 44th Annual Meeting of Korean Cancer Association & 4th International Cancer Conference 초록접수 Plenary Speakers 연장접수 마감 ㅣ 2018년 4월 20일(금) Peter Campbell, PhD Head, Cancer Genetics & Genomics, Wellcome Trust Sanger Institute, UK 접수방법 Interrogating the architecture of cancer genomes 대한암학회 홈페이지 ( 접수하여 주십시오. 세부 형식은 홈페이지를 참고하시기 바랍니다. 발표유형 Outstanding Abstract Session (발표언어 ENG ) 접수된 초록 중 암 관련 국제 대회에서 발표되지 않은 Original 연구로 Frank McCormick, PhD, FRS scientific, clinical impact가 큰 초록을 학술위원회에서 선정합니다. Professor, UCSF Helen Diller Family Comprehensive Cancer Center, USA International Session (발표언어 ENG ) 국내 및 해외 연구자의 초록이 발표되며 영어로 진행합니다. New ways of targeting Ras Oral Presentation (발표언어 KOR ) 국내 연구자들의 초록이 발표되며 한국어로 진행합니다. Dong-Young Noh, MD, PhD Poster Presentation Professor of Surgery, Seoul National University College of Medicine, Korea Translational research in surgical oncology Merit Awards 국내 우수 초록 발표자 15명을 선정하여 6월 22일 폐회식에서 시상합니다. 수상 자격은 대한암학회 회원에 한합니다. Ho-Young Lee, PhD Professor, Seoul National University College of Pharmacy, Korea Key strategies to overcome anticancer drug resistance in non-small cell lung cancer Rank 수상자 1명 2명 12명 상금 200만원 100만원 50만원 3

4 4 44 th Annual Meeting of Korean Cancer Association & 4 th International Cancer Conference 제44차대한암학회학술대회및제4차국제암컨퍼런스 5 Thursday, June 21 Thursday, June 21 Location Crystal Ballroom (2F) Pine Room (3F) Sapphire Ballroom (3F) Belle-vue Suite (36F) Emerald (2F) Room Room A Room B Room C Room A Room B Room C 08:00-09:00 Registration Registration ES-1 KOR ES-2 KOR SP-1 ENG SP-2 ENG YIS KOR MC-1 ENG 09:00-10:40 Foundation of precision oncology Progress in surgical treatment for malignant disease Emerging molecular segments in gastrointestinal cancer Clinical trials and molecular imaging biomarkers Young Investigator Symposium Time-traveling in the IO space: Investigate the current status and foresight the IO space 10:40-11:00 Coffee Break Coffee Break 11:00-11:30 PL-1 ENG Prof. Ho-Young Lee 11:30-12:20 PL-2 ENG Dr. Peter Campbell 12:20-13:20 SS-1 ENG (by MSD) SS-2 ENG (by ONO/BMS) SS-3 ENG (by Novartis) Poster Presentation 1 (09:00-17:00) SP-3 ENG SP-4 ENG SP-5 KOR IS-1 ENG ES-3 KOR SP-6 ENG SP-7 ENG MC-2 ENG 13:20-15:00 Plasma genotyping for precision medicine Change of surgical strategy by multidisciplinary treatment Key issues in biosimilars International Session 1 Genomic and immuno-oncology era in radiation oncology Recent progress in cancer epigenomics Microenvironment and tumorigenesis 1 Evaluating current and emerging strategies using checkpoint inhibitors: Where are we now and where are we going? 15:00-15:20 Coffee Break Coffee Break SP-8 ENG SP-9 KOR SP-10 ENG IS-2 ENG SP-11 ENG SP-12 ENG SP-13 ENG MC-3 ENG 15:20-17:00 Personalized cancer immunotherapy Hospice and palliative care Genomic alterations in premalignant lesions International Session 2 Bio-medical research using big accelerators Optimization of adjuvant systemic treatment for EBC Microenvironment and tumorigenesis 2 Towards precision healthcare: Overcoming the challenges of NGSbased cancer profiling 17:00-18:00 Oral Presentations KOR / International Sessions ENG Oral Presentations KOR / International Sessions ENG Session Remarks SP-03 Joint Symposium (Korean Cancer Association & Korean Society for Laboratory Medicine) SP-07, 13 Joint Symposia (Korean Cancer Association & Shanghai Cancer Institute) SP-10 Joint Symposium (Korean Cancer Association & The Korean Society of Pathologists) SP-11 The Center for Korean Users of Heavy-Ion Facilities Symposium PL : Plenary Lecture ES : Educational Session SP : Symposium MC : Master Class SS : Satellite Symposium IS : International Session Oral presentations in English

5 6 44 th Annual Meeting of Korean Cancer Association & 4 th International Cancer Conference 제44차대한암학회학술대회및제4차국제암컨퍼런스 7 Friday, June 22 Friday, June 22 Location Room Crystal Ballroom (2F) Pine Room (3F) Sapphire Ballroom (3F) Belle-vue Suite (36F) Emerald (2F) Room A Room B Room C Room A Room B Room C 08:00-09:00 Registration Registration 09:00-10:00 Outstanding Abstract Session ENG Oral Presentations KOR / International Sessions ENG 10:00-10:20 Coffee Break Coffee Break 10:20-10:50 PL-3 ENG Prof. Dong-Young Noh 10:50-11:40 PL-4 ENG Prof. Frank McCormick 11:50-12:50 SS-4 ENG (by Roche) SS-5 ENG (by Lilly) 12:50-13:20 KCA General Assembly SS-6 ENG (by Pfizer) Poster Presentation 2 13:20-13:40 Break Break (09:00-17:00) SP-14 KOR SP-15 ENG IS-3 ENG SP-16 ENG SP-17 ENG SP-18 ENG MC-4 ENG 13:40-15:20 Promising anticancer drug pipeline in pre-clinical and clinical stages in Korea Tailored care for young women with cancer International Session 3 Recent updates and future perspectives on the hepato-biliary cancer Current debate in the oncologic management of rectal cancer Multi-omics approaches in cancer research A forum on tumor microenvironment 15:20-15:40 Coffee Break Coffee Break SP-19 ENG SP-20 ENG SP-21 ENG IS-4 ENG SP-22 ENG SP-23 KOR 15:40-17:20 Multifocal lung cancer: The same of different? Aggressive or conservative? Multidisciplinary care of BRCA mutation carriers Update of gastric cancer research in Korea International Session 4 Tumor immunity and immunotherapy From scientific lead to companion diagnostics (CDx) approval process in Korea 17:30-19:00 Closing Athenee Garden (3rd Floor) Closing Athenee Garden (3rd Floor) Session Remarks SP-14 National OncoVenture Symposium SP-18 Joint Symposium (Korean Cancer Association & Korea Genome Organization) SP-20 Joint Symposium (Korean Cancer Association & Korean Society of Gynecologic Oncology) SP-22 Joint Symposium (Korean Cancer Association & Beijing Medical Association) PL : Plenary Lecture SP : Symposium MC : Master Class SS : Satellite Symposium IS : International Session Oral presentations in English

6 8 44 th Annual Meeting of Korean Cancer Association & 4 th International Cancer Conference 제44차대한암학회학술대회및제4차국제암컨퍼런스 9 Thursday, June 21 Educational Session 3 KOR 13:20-15:00, Sapphire Ballroom A Plenary Lecture 1 ENG Key strategies to overcome anticancer drug resistance in non-small cell lung cancer Ho-Young Lee (Seoul National University College of Pharmacy) Plenary Lecture 2 ENG Interrogating the architecture of cancer genomes Peter Campbell (Wellcome Trust Sanger Institute, UK) 11:00-11:30, Crystal Ballroom 11:30-12:20, Crystal Ballroom Genomic and immuno-oncology era in radiation oncology ➊ Maneuvering or mining the BIGGER data O Kyu Noh (Ajou University School of Medicine) ➋ Genomic and immunogenomic approach for prediction of radiation response In Ah Kim (Seoul National University College of Medicine) ➌ Immune-modulating radiotherapy or vice versa Si Yeol Song (University of Ulsan College of Medicine) ➍ Precision medicine based on RadioGenome using artificial intelligence Wonil Jang (Korea Institute of Radiological & Medical Sciences) Educational Session 1 KOR 09:00-10:40, Crystal Ballroom A Young Investigator Symposium KOR 09:00-10:40, Sapphire Ballroom C Foundation of precision oncology ➊ Deep learning for predicting patient-specific cancer vulnerabilities Jung Kyoon Choi (Korea Advanced Institute of Science and Technology (KAIST) ➋ Application of PDX technology combined with cancer genome information for precision oncology Jong-Il Kim (Seoul National University College of Medicine) ➌ Multi-platform genomic and epigenomic landscape of hepatocarcinogenesis Hyun Goo Woo (Ajou University School of Medicine) ➍ Precision oncology platform for oncologists Jeeyun Lee (Sungkyunkwan University School of Medicine) ➊ Spliceosomal gene mutations in cancer Eunhee Kim (Ulsan National Institute of Science and Technology (UNIST) ➋ Updates in breast cancer genomics Jisun Kim (University of Ulsan College of Medicine) ➌ Genomic architectures of fusion oncogene driven lung adenocarcinoma Young Seok Ju (Korea Advanced Institute of Science and Technology (KAIST) ➍ Genome wide association study for thyroid cancer and thyroid diseases Yul Hwangbo (Natioanl Cancer Center) Educational Session 2 KOR 09:00-10:40, Crystal Ballroom B Progress in surgical treatment for malignant disease ➊ Robotic rectal cancer surgery: surpass laparoscopic resection? Gyu-Seog Choi (Kyungpook National University School of Medicine) ➋ Laparoscopic liver resection: Real advantage? Ki-Hun Kim (University of Ulsan College of Medicine) ➌ Breast reconstruction: Related to the better life? Jeong Eon Lee (Sungkyunkwan University School of Medicine) ➍ Pylorus preserving gastrectomy & KLASS-04 Hyuk-Joon Lee (Seoul National University College of Medicine) Symposium 01 ENG Emerging molecular segments in gastrointestinal cancer 09:00-10:40, Crystal Ballroom C ➊ Overcoming tumor heterogeneity in GI cancer: the PANGEA trial Daniel Catenacci (The University of Chicago Medical Center & Biological Sciences, USA) ➋ Effective molecular target therapy for heterogeneous GI cancer Keun-Wook Lee (Seoul National University Bundang Hospital) ➌ A close look into the immune signature of gastric cancer Taroh Satoh (Osaka University Graduate School of Medicine, Japan)

7 10 44 th Annual Meeting of Korean Cancer Association & 4 th International Cancer Conference 제44차대한암학회학술대회및제4차국제암컨퍼런스 11 Thursday, June 21 Symposium 05 KOR Key issues in biosimilars 13:20-15:00, Crystal Ballroom C Symposium 02 ENG Clinical trials and molecular imaging biomarkers 09:00-10:40, Sapphire Ballroom B ➊ Quantitative imaging of cancer to precisely phenotype patients and tumors, to predict and assess treatment response Richard Leo Wahl (Washington University School of Medicine in St. Louis, USA) ➊ Approaches and interactions in biosimilar development HoUng Kim (Celltrion Healthcare, Co., Ltd.) ➋ Regulatory issues in MFDS perspectives: MFDS ➌ Clinical issues: Benefits and drawbacks of biosimilars: Oncologist In Hae Park (National Cancer Center) ➍ To be an interchangeable drug: Future direction of research Tae-Yong Kim (Seoul National University College of Medicine) ➋ Role of imaging in lymphoma Joohyun O (The Catholic University of Korea College of Medicine) ➌ Molecular imaging biomarkers in lung and esophageal cancers for clinical trials Joon Young Choi (Sungkyunkwan University School of Medicine) ➍ Role of metabolic imaging in response assessment to standardized chemotherapy in advanced gastric cancer Seunggyun Ha (Seoul National University College of Medicine) Symposium 03 ENG Plasma genotyping for precision medicine ➊ Circulating tumor DNA as a liquid biopsy: Overview Jong-Won Kim (Sungkyunkwan University School of Medicine) 13:20-15:00, Crystal Ballroom A Joint Symposium (Korean Cancer Association & Korean Society for Laboratory Medicine) ➋ cfdna EGFR mutation detection Kyung A Lee (Yonsei University College of Medicine) ➌ Plasma genotyping for breast and other cancers Sun-Young Kong (National Cancer Center) Symposium 06 ENG Recent progress in cancer epigenomics ➊ Targeted bisulfite sequencing of DNA methylation markers for blood-based detection of colorectal cancers Gyeong Hoon Kang (Seoul National University College of Medicine) ➋ MiR-34a regulates breast cancer stemness and chemoresistance Jong Hoon Park (Sookmyung Women s University) ➌ TET-family methylcytosine oxidases in stem cells and cancer Myunggon Ko (Ulsan National Institute of Science and Technology (UNIST) 13:20-15:00, Sapphire Ballroom B ➍ Nuclear export of HP1γ is responsible for HPV-mediated p53 degradation in cervical cancer So Hee Kwon (Yonsei University College of Pharmacy) ➍ Plasma sequencing for chromosomal instability detection Eunhae Cho (Green Cross Genome) Symposium 07 ENG 13:20-15:00, Sapphire Ballroom C Symposium 04 ENG Change of surgical strategy by multidisciplinary treatment 13:20-15:00, Crystal Ballroom B ➊ Upfront surgery vs. neoadjuvant chemotherapy for marginally resectable pancreatic cancer Kyu-Pyo Kim (University of Ulsan College of Medicine) ➋ Reality of rectum preservation for locally advanced rectal cancer after preoperative chemoradiotherapy Kil Yeon Lee (Kyung Hee University School of Medicine) ➌ Conversion surgery after systemic chemotherapy for metastatic gastric cancer Oh Jeong (Chonnam National University Medical School) ➍ Determination of lymph node dissection after neoadjuvant chemotherapy for breast cancer Eun Sook Lee (National Cancer Center) Joint Symposium (Korean Cancer Association & Shanghai Cancer Institute) Microenvironment and tumorigenesis 1 ➊ Enriched environment boosts NK cell anti-tumor immunity via peripheral sympathetic nerves Yu Gan (Shanghai Cancer Institute, China) ➋ Elimination of a specific subpopulation of T cells overcomes castration-resistance in prostate cancer therapy Wei-Qiang Gao (Shanghai Cancer Institute, China) ➌ The mechanism and pathological features of the oncogenic KRAS stabilization by APC loss in colorectal cancer Kang-Yell Choi (Yonsei University College of Life Science and Biotechnology) ➍ Metabolic regulation of hypoxia responses Young Il Yeom (Korea Research Institute of Bioscience & Biotechnology (KRIBB)

8 12 44 th Annual Meeting of Korean Cancer Association & 4 th International Cancer Conference 제44차대한암학회학술대회및제4차국제암컨퍼런스 13 Thursday, June 21 Symposium 11 ENG 15:20-17:00, Sapphire Ballroom A The Center for Korean Users of Heavy-Ion Facilities Symposium Bio-medical research using big accelerators Symposium 08 ENG Personalized cancer immunotherapy ➊ HLA-based personalized T cell therapy Se-Ho Park (Korea University) ➋ Personalized cancer immunotherapy using microbiome Hansoo Park (Gwangju Institute of Science and Technology (GIST) ➌ Chimeric antigen receptor T-cell therapy for B-cell non-hodgkin lymphoma Shinichi Makita (National Cancer Center Hospital, Japan) ➍ Computational prediction of somatic mutation driven neoantigens Sangwoo Kim (Yonsei University College of Medicine) Symposium 09 KOR Hospice and palliative care ➊ Hospice and palliative care policy in South Korea Yoon-Jung Chang (National Cancer Center) 15:20-17:00, Crystal Ballroom B ➋ Criteria and status of hospice and palliative care for terminal cancer patients Jung-Hye Kwon (Kangdong Sacred Heart Hospital) ➌ Practice case of hospice and palliative care for terminal cancer patients (inpatient, homecare, shared care) Su-jin Koh (Ulsan University Hospital) Symposium 10 ENG Genomic alterations in premalignant lesions ➊ Genomic alterations in gastric cancer precursor lesions Kyoung Mee Kim (Sungkyunkwan University School of Medicine) 15:20-17:00, Crystal Ballroom A ➋ Genomic alterations in dysplastic nodule and early hepatocellular carcinoma Young Nyun Park (Yonsei University College of Medicine) ➌ Genomic alterations in preinvasive lesions of lung cancer Hyo Sup Shim (Yonsei University College of Medicine) 15:20-17:00, Crystal Ballroom C Joint Symposium (Korean Cancer Association & The Korean Society of Pathologists) ➍ Molecular alterations in serrated precursor lesions of colorectal cancer Jung Ho Kim (Seoul National University Hospital) ➊ Potential use of synchrotron radiation for bio-medical studies Jae-Hong Lim (Pohang Accelerator Laboratory) ➋The status of KOMAC and its bio-medical applications Kye Ryung Kim (Korea Atomic Energy Research Institute (KAERI) ➌ Status and opportunities for medical research with RAON Young Kwan Kwon (Institute for Basic Science (IBS) ➍ Biomedical research using heavy ions Symposium 12 ENG Optimization of adjuvant systemic treatment for EBC ➊ Personalized approach in breast cancer to balance treatment outcome and patients quality of life Edith Perez (Roche, USA) ➋ Optimal duration and treatment for ER(+) breast cancer: Current evidence and future Jee Hyun Kim (Seoul National University Bundang Hospital) ➌ Ramification of adjuvant anti-her2 treatment: The more is the better? Keun Seok Lee (National Cancer Center) ➍ Better strategies of adjuvant treatment for TNBC Joohyuk Sohn (Yonsei University College of Medicine) Symposium 13 ENG Microenvironment and tumorigenesis 2 15:20-17:00, Sapphire Ballroom B ➊ Rac GTPase Activating Protein 1 activates Yes-associated Protein that targets nucleoporin TPR to promote hepatocellular carcinoma cytokinesis and growth Zhi-Gang Zhang (Shanghai Cancer Institute, China) ➋ Tumor microenvironment: a bioinformatic perspective Guanglei Zhuang (Shanghai Cancer Institute, China) 15:20-17:00, Sapphire Ballroom C Joint Symposium (Korean Cancer Association & Shanghai Cancer Institute) ➌ Systems pharmacology approaches for target & drug discovery towards cancer precision medicine Wan Kyu Kim (Ewha Womans University) ➍ Discovery of bortezomib as a metastasis inhibitor to target GALNT14-TGFb metastatic pathway by Connectivity MAP based drug repositioning Hyuk-Jin Cha (Seoul National University College of Pharmacy)

9 14 44 th Annual Meeting of Korean Cancer Association & 4 th International Cancer Conference 제44차대한암학회학술대회및제4차국제암컨퍼런스 15 Thursday, June 21 Satellite Symposium 1 (by MSD) ENG The art of immuno-therapy in NSCLC 12:20-13:20, Crystal Ballroom Master Class 1 ENG Time-traveling in the IO space: Investigate the current status and foresight the IO space ➊ Past: What happened? Overview of keynote trials 09:00-10:40, Belle-vue Suite (36F) Satellite Symposium 2 (by ONO/BMS) ENG Emerging horizons in gastric cancer immunotherapy Min-Hee Ryu (University of Ulsan College of Medicine) 12:20-13:20, Sapphire Ballroom B ➋ Present: What s going on? Moving from indistinct approaches to a patient specific approach using biomarker ➌ Future: What s coming? Define future clinical combination strategy Satellite Symposium 3 (by Novartis) ENG Ceritinib: How to optimize treatment of ALK + NSCLC in 1L 12:20-13:20, Sapphire Ballroom C Master Class 2 ENG 13:20-15:00, Belle-vue Suite (36F) International Session 1 ENG 13:20-15:00, Pine Room Evaluating current and emerging strategies using checkpoint inhibitors: Where are we now and where are we going? International Session 2 ENG 15:20-17:00, Pine Room ➊ CheckMate in various tumor type Oral Presentations KOR / International Sessions ENG 17:00-18:00 ➋ Combination is better than single? Ji-Youn Han (National Cancer Center) ➌ Exploring opportunities to improve outcomes via Patient Selection Ross Soo (National University Cancer Institute, Singapore) Poster Presentation 1 09:00-17:00, Emerald Room Master Class 3 ENG 15:20-17:00, Belle-vue Suite (36F) Towards precision healthcare: Overcoming the challenges of NGS-based cancer profiling ➊ Pathologist perspective: better use of limited precious samples ➋ Road to overcome current hurdles and limitations using NGS Tariq Mughal (Foundation Medicine, USA) ➌ Oncologist experiences: clinical application of comprehensive genomic profiling

10 16 44 th Annual Meeting of Korean Cancer Association & 4 th International Cancer Conference 제44차대한암학회학술대회및제4차국제암컨퍼런스 17 Friday, June 22 Symposium 16 ENG 13:40-15:20, Sapphire Ballroom A Plenary Lecture 3 ENG Translational research in surgical oncology Dong-Young Noh (Seoul National University College of Medicine) 10:20-10:50, Crystal Ballroom Recent updates and future perspectives on the hepato-biliary cancer ➊ Recent advances in HCC systemic therapy - Where do we go from here? Ahmed Kaseb (MD Anderson Cancer Center, USA) ➋ Now, we re getting Immune-therapy in HCC Masafumi Ikeda (National Cancer Center Hospital East, Japan) ➌ Recent treatment updates on the biliary tract cancer Do-Youn Oh (Seoul National University College of Medicine) Plenary Lecture 4 ENG 10:50-11:40, Crystal Ballroom New ways of targeting Ras Frank McCormick (UCSF Helen Diller Family Comprehensive Cancer Center, USA) Symposium 14 KOR National OncoVenture Symposium ➊ Introduction of National OncoVenture (NOV) Young-Whan Park (National OncoVenture) ➋ First-in-human phase 1 trial of anti-hepatocyte growth factor (HGF) antibody (YYB101, NOV1105) in refractory solid tumor Jeeyun Lee (Sungkyunkwan University School of Medicine) ➌ New vascular disrupting agent CKD-516 (NOV1204) development Kee-won Kim (Chong Kun Dang Pharm) ➍ NOV1501/ABL001 A bispecific antibody targeting VEGF & DLL4 for cancer treatment Sang Hoon Lee (ABL Bio Inc.) Symposium 15 ENG Tailored care for young women with cancer ➊ Genomic landscape of Korean young breast cancer patients Yeon Hee Park (Sungkyunkwan University School of Medicine) ➋ Ethical dilemmas around genetic testing and clinical management ➌ Strategies for fertility preservation Jayeon Kim (CHA University School of Medicine) ➍ Screening in dense breast: Challenges and options Woo Kyung Moon (Seoul National University College of Medicine ) 13:40-15:20, Crystal Ballroom A Promising anti-cancer drug pipeline in pre-clinical and clinical stages in Korea 13:40-15:20, Crystal Ballroom C Symposium 17 ENG Current debate in the oncologic management of rectal cancer ➊ Total neoadjuvant therapy (TNT) for rectal cancer Hyung Jin Kim (The Catholic University of Korea College of Medicine) ➋ Can radiation be omitted? Se-Jin Baek (Korea University College of Medicine) ➌ Update MR imaging in rectal cancer Seung Hyun Cho (Kyungpook National University School of Medicine) 13:40-15:20, Sapphire Ballroom B ➍ Prevention and prediction of local recurrence after curative rectal cancer surgery Soo Yeun Park (Kyungpook National University School of Medicine) Symposium 18 ENG Joint Symposium (Korean Cancer Association & Korea Genome Organization) Multi-omics approaches in cancer research ➊ Chemical genomics approach for discovery of biomarker-driven intervention opportunities Hyun Seok Kim (Yonsei University College of Medicine) ➋ Doxorubicin induces PKR-mediated apoptosis via suppressing the non-coding RNA nc886 Yong Sun Lee (National Cancer Center) ➌ Proteomic multimarker panel improves diagnostic performance of early hepatocellular carcinoma Youngsoo Kim (Seoul National University College of Medicine) ➍ A transfer RNA derived small RNA regulates mrna translation and potential target for hepatocellular carcinoma Hak Kyun Kim (Stanford University, USA) 13:40-15:20, Sapphire Ballroom C

11 18 44 th Annual Meeting of Korean Cancer Association & 4 th International Cancer Conference 제44차대한암학회학술대회및제4차국제암컨퍼런스 19 Friday, June 22 Symposium 22 ENG 15:40-17:20, Sapphire Ballroom B Symposium 19 ENG 15:40-17:20, Crystal Ballroom A Multifocal lung cancer: The same of different? Aggressive or conservative? ➊ Radiologist's view ➋ Pathiologist's view ➌ Thoracic surgeon's view ➍ Medical oncologist's view Joint Symposium (Korean Cancer Association & Beijing Medical Association) Tumor immunity and immunotherapy ➊ Status of immunotherapy for cancer patients in China Ping Zhao (China Cancer Foundation, China) ➋ Regular T cells and their potential in clinical application Xundong Wei (Biotherapy Center, Beijing Hospital, China) ➌ Byoung Chul Cho (Yonsei University College of Medicine) ➍ Overcoming immune cell exhaustion by a new APC based vaccine Chang-Yuil Kang (Seoul National University College of Pharmacy) Symposium 20 ENG Multidisciplinary care of BRCA mutation carriers ➊ Genetic testing, counselling, and issues in clinical application Han-Byoel Lee (Seoul National University College of Medicine) ➋ Breast cancer surveillance and risk-reducing mastectomy Sang-Ah Han (Kyung Hee University School of Medicine) ➌ Ovarian cancer surveillance and risk-reducing surgery Myong Cheol Lim (National Cancer Center) ➍ Systemic therapy for ovarian cancer with BRCA mutation Yong Wha Moon (CHA University School of Medicine) 15:40-17:20, Crystal Ballroom B Joint Symposium (Korean Cancer Association & Korean Society of Gynecologic Oncology) Symposium 23 KOR From scientific lead to companion diagnostics (CDx) approval process in Korea ➊ Developing ddpcr EGFR mutation test as CDx: Sharing experience for CDx approval Sang-Rae Cho (GeneCurix) 15:40-17:20, Sapphire Ballroom C ➋ Clinical NGS diagnostics: NGS assay selection, validation and approval Se Jin Jang (University of Ulsan College of Medicine) ➌ Experience in NGS-based in vitro diagnostic medical device development for cancer gene testing Kwang Joong Kim (NGeneBio) ➍ Omics technology: Developing prediction assay for CDx platform in academia Kyoung Mee Kim (Sungkyunkwan University School of Medicine) Symposium 21 ENG 15:40-17:20, Crystal Ballroom C Update of gastric cancer research in Korea ➊ Feasibility of laparoscopic gastrectomy for advanced gastric cancer (result of COACT 1001 trial) Young-Woo Kim (National Cancer Center) ➋ Olaparib for management of advanced gastric cancer Do-Youn Oh (Seoul National University College of Medicine) ➌ Immunotherapy for advanced gastric cancer Yoon-Koo Kang (University of Ulsan College of Medicine) ➍ Role of eradication of Helicobacter pylori after endoscopic resection of gastric cancer Il Ju Choi (National Cancer Center) Master Class 4 ENG A forum on tumor microenvironment ➊ Targeting TME Vasculature and Stroma ➋ Research Effort in TME ➌ Targeting TME Vasculature and GC 13:40-15:20, Belle-vue Suite (36F)

12 20 44 th Annual Meeting of Korean Cancer Association & 4 th International Cancer Conference 제44차대한암학회학술대회및제4차국제암컨퍼런스 21 Friday, June 22 사전등록 Satellite Symposium 4 (by Roche) ENG Harnessing the power of immunotherapy and targeted therapy in lung cancer 11:50-12:50, Crystal Ballroom 사전등록 등록비 접수마감 : 2018년 5월 31일 ( 목 ) 마감일이후에는현장등록만가능합니다. 대한암학회홈페이지 ( 에서등록하여주십시오. 등록신청후사전등록기간내에입금이확인되지않은경우, 등록이취소됩니다. 구분사전등록 (-5/31) 현장등록 교수및전문의 100,000 원 120,000 원 Satellite Symposium 5 (by Lilly) ENG Current status and real world experience of anti-angiogenesis in Advanced Gastric Cancer Taroh Satoh (Osaka University Graduate School of Medicine, Japan) 11:50-12:50, Sapphire Ballroom B 대한암학회회원 전공의, 연구원 ( 학교및병원 ), 기타연구소 ( 연구원 ) 및업체대한병리학회회원 50,000 원 100,000 원 70,000 원 120,000 원 Satellite Symposium 6 (by Pfizer) ENG 11:50-12:50, Sapphire Ballroom C 공동심포지엄참여학회회원 대한부인종양학회회원대한진단검사의학회회원한국유전체학회회원 100,000 원 120,000 원 Recent updates of Crizotinib in ALK+ & ROS1 NSCLC 교수및전문의 120,000 원 150,000 원 비회원 전공의, 연구원 ( 학교및병원 ), 학생, 간호사, 기타 70,000 원 90,000 원 Outstanding Abstract Session ENG 09:00-10:00, Crystal Ballroom 연구소 ( 연구원 ) 및업체 120,000 원 150,000 원 * 암학회정회원및준회원은연회비 30,000 원을함께송금하여주십시오. Oral Presentations KOR / International Sessions ENG 09:00-10:00 * 65 세이상암학회회원은등록비가면제되오니등록신청만해주시기바랍니다. International Session 3 ENG 13:40-15:20, Pine Room 결제방법 온라인카드결제 ( 대회홈페이지에서결제 ) 은행송금 : 신한은행 ( 예금주 : 대한암학회 ) International Session 4 ENG 15:40-17:20, Pine Room 평점안내 대한의사협회평점 : 12점 (1일당 6점 ) / 부분평점인정가능 전공의스티커 : 1장 Poster Presentation 2 09:00-17:00, Emerald Room 취소및환불 2018년 5월 31일 ( 목 ) 까지취소요청이접수된경우에만환불이가능합니다. 환불금액은절차에필요한수수료를공제후대회종료일로부터 30일이내에반환됩니다. 대한암학회사무국서울특별시종로구새문안로 92 광화문오피시아 1824 호 (03186) Tel 02) Fax 02) cancer@kams.or.kr